38 related articles for article (PubMed ID: 9467659)
1. Cellular immune responses in acute leukaemia patients with severe chemotherapy-induced leucopenia; characterization of the cytokine repertoire of clonogenic T cells.
Bruserud O
Cancer Immunol Immunother; 1998 Jun; 46(4):221-8. PubMed ID: 9671145
[TBL] [Abstract][Full Text] [Related]
2. Soluble Fas/Apo-1 (CD95) levels during T cell activation in the presence of acute myelogenous leukemia accessory cells; contributions from local release and variations in systemic levels.
Bruserud O; Ulvestad E
Cancer Immunol Immunother; 2000 Sep; 49(7):377-87. PubMed ID: 10999464
[TBL] [Abstract][Full Text] [Related]
3. Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts; studies of normal polyclonal T cells and T lymphocyte clones derived early after allogenic bone marrow transplantation.
Bruserud O; Pawelec G
Cancer Immunol Immunother; 1996 Mar; 42(3):133-40. PubMed ID: 8640841
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-13 secretion by normal and posttransplant T lymphocytes; in vitro studies of cellular immune responses in the presence of acute leukaemia blast cells.
Bruserud O; Pawelec G
Cancer Immunol Immunother; 1997 Oct; 45(1):45-52. PubMed ID: 9353426
[TBL] [Abstract][Full Text] [Related]
5. Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts: studies of allostimulated interferon-gamma secretion.
Bruserud O; Mentzoni L; Foss B; Bergheim J; Berentsen S; Nesthus I
Cancer Immunol Immunother; 1996 Dec; 43(5):275-82. PubMed ID: 9024504
[TBL] [Abstract][Full Text] [Related]
6. Generation of cytotoxic T lymphocytes from peripheral blood of leukaemic patients.
Nouri AM; Dorey E; Davis CL; Rohatiner A; Lister TA; Oliver RT
Cancer Immunol Immunother; 1993 Jul; 37(1):47-53. PubMed ID: 8513452
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytes from B-acute lymphoblastic leukemia patients present differential regulation of the adenosinergic axis depending on risk stratification.
Brum da Silva Nunes V; Kehl Dias C; Nathali Scholl J; Nedel Sant'Ana A; de Fraga Dias A; Granero Farias M; Alegretti AP; Sosnoski M; Esteves Daudt L; Bohns Michalowski M; Oliveira Battastini AM; Paz AA; Figueiró F
Discov Oncol; 2022 Dec; 13(1):143. PubMed ID: 36581667
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia.
Smits EL; Lee C; Hardwick N; Brooks S; Van Tendeloo VF; Orchard K; Guinn BA
Cancer Immunol Immunother; 2011 Jun; 60(6):757-69. PubMed ID: 21519825
[TBL] [Abstract][Full Text] [Related]
9. Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience.
Liseth K; Ersvaer E; Hervig T; Bruserud Ø
J Biomed Biotechnol; 2010; 2010():692097. PubMed ID: 20625438
[TBL] [Abstract][Full Text] [Related]
10. Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells.
Ersvaer E; Liseth K; Skavland J; Gjertsen BT; Bruserud Ø
BMC Immunol; 2010 Jul; 11():38. PubMed ID: 20618967
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy prospects for acute myeloid leukaemia.
Barrett AJ; Le Blanc K
Clin Exp Immunol; 2010 Aug; 161(2):223-32. PubMed ID: 20529084
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts.
Le Dieu R; Taussig DC; Ramsay AG; Mitter R; Miraki-Moud F; Fatah R; Lee AM; Lister TA; Gribben JG
Blood; 2009 Oct; 114(18):3909-16. PubMed ID: 19710498
[TBL] [Abstract][Full Text] [Related]
13. T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-gamma that can be further increased by a novel protein kinase C agonist PEP005.
Ersvaer E; Hampson P; Hatfield K; Ulvestad E; Wendelbo Ø; Lord JM; Gjertsen BT; Bruserud Ø
Cancer Immunol Immunother; 2007 Jun; 56(6):913-25. PubMed ID: 17115221
[TBL] [Abstract][Full Text] [Related]
14. In vitro culture of human osteosarcoma cell lines: a comparison of functional characteristics for cell lines cultured in medium without and with fetal calf serum.
Bruserud O; Tronstad KJ; Berge R
J Cancer Res Clin Oncol; 2005 Jun; 131(6):377-84. PubMed ID: 15776274
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia.
Wendelbo Ø; Nesthus I; Sjo M; Paulsen K; Ernst P; Bruserud Ø
Cancer Immunol Immunother; 2004 Aug; 53(8):740-7. PubMed ID: 15133630
[TBL] [Abstract][Full Text] [Related]
16. Human acute lymphoblastic leukemia (ALL) blasts as accessory cells during T-cell activation: differences between patients in costimulatory capacity affect proliferative responsiveness and cytokine release by activated T cells.
Bruserud O; Ulvestad E
Cancer Immunol Immunother; 2003 Apr; 52(4):215-25. PubMed ID: 12669246
[TBL] [Abstract][Full Text] [Related]
17. T-lymphocyte functions in acute leukaemia patients with severe chemotherapy-induced cytopenia: characterization of clonogenic T-cell proliferation.
Bruserud O; Ulvestad E; Berentsen S; Bergheim J; Nesthus I
Scand J Immunol; 1998 Jan; 47(1):54-62. PubMed ID: 9467659
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
